GL1X · GenesisL1 explorer

Research workbench

Design and biological evaluation of novel, balanced dual PPARA/G agonists

Analyse Design and biological evaluation of novel, balanced dual PPARA/G agonists in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FEJ
Type
protein
Length
268 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; Peptide motif 3 of nuclear receptor…
UniProt
P37231, Q15788
Ligands
CTM
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25866% helix, 5% strandP37231
BPeptide motif 3 of nuclear receptor coactivator 1protein1070% helix, 0% strandQ15788

Ligands and binding sites

  • CTM · (2S)-3-(4-{[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methoxy}-2-methylphenyl)-2-ethoxypropanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14740.790.8654CTM
2740.410.7915empty

Interfaces

1 interface between chains.

  • A–B · 535 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3FEJ · Design and biological evaluation of novel, balanced dual PPARa/g agonists · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.